STOCK TITAN

Avidity Biosciences, Inc. SEC Filings

RNAM Nasdaq

Welcome to our dedicated page for Avidity Biosciences SEC filings (Ticker: RNAM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Avidity Biosciences's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Avidity Biosciences's regulatory disclosures and financial reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many Avidity Biosciences (RNAM) SEC filings are available on StockTitan?

StockTitan tracks 1 SEC filings for Avidity Biosciences (RNAM), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Avidity Biosciences (RNAM)?

The most recent SEC filing for Avidity Biosciences (RNAM) was filed on March 9, 2026.

RNAM Rankings

RNAM Stock Data

11.25B
146.28M
Biotechnology
Healthcare
Link
United States
San Diego

RNAM RSS Feed